Company Filing History:
Years Active: 2016-2017
Title: Arnaud Debin: Innovator in Immunology
Introduction
Arnaud Debin is a notable inventor based in Escalquens, France. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Debin's work focuses on the development of compounds that can enhance immune responses.
Latest Patents
Debin's latest patents include groundbreaking research on conjugated TLR7 and/or TLR8 and TLR2 agonists. This patent describes a conjugated compound of the formula Q-Z—R, wherein Q is a TLR7 and/or TLR8 agonist, and Z—R is a TLR2 agonist. The applications of this compound are aimed at treating infections, cancer, or immune disorders, as well as for use in vaccines. Another significant patent involves compositions of TLR7 and/or TLR8 agonists conjugated to lipids. This patent outlines a conjugated compound of the formula Q-Z—R, where Q is a TLR7 and/or TLR8 agonist, and Z—R is a lipid covalently linked to an amino acid or peptide coupled to a polyamine group. The patent also discusses the manufacturing process of the conjugated compound and its use in pharmaceutical compositions for treating various health conditions.
Career Highlights
Arnaud Debin is currently associated with Invivogen, a company known for its focus on immunology and biotechnology. His work at Invivogen has allowed him to explore innovative solutions in the treatment of diseases through immune modulation.
Collaborations
Debin collaborates with esteemed colleagues such as Fabienne Vernejoul and Daniel Drocourt. Their combined expertise contributes to the advancement of research in immunology and the development of new therapeutic strategies.
Conclusion
Arnaud Debin's contributions to immunology through his patents and work at Invivogen highlight his role as a significant innovator in the field. His research continues to pave the way for new treatments and therapies that can improve health outcomes.